SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027586
Filing Date
2023-06-13
Accepted
2023-06-13 07:29:19
Documents
16
Period of Report
2023-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230612.htm   iXBRL 8-K 110021
2 EX-2.1 gls-ex2_1.htm EX-2.1 1202763
3 EX-10.1 gls-ex10_1.htm EX-10.1 144401
4 EX-10.2 gls-ex10_2.htm EX-10.2 67950
5 EX-10.3 gls-ex10_3.htm EX-10.3 89806
  Complete submission text file 0000950170-23-027586.txt   1919754

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230612_lab.xml EX-101.LAB 12409
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230612_pre.xml EX-101.PRE 10193
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230612.xsd EX-101.SCH 2465
10 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230612_htm.xml XML 4356
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 231010240
SIC: 2834 Pharmaceutical Preparations